The Scottish Life Sciences Covid-19 Strategic Response Plan

Symbiosis CEO Colin MacKay is a proud member of the ILG (Life Sciences Industry Leadership Group) and they have just announced their Scottish Life Sciences Covid-19 Strategic Response Plan.Following the outstanding response to Covid19 by the Scottish life sciences sector, the Industry Leadership Group have identified the priority areas of focus for the sector to ensure patients have access to new and… Read More

Life Sciences Innovation and Responding to COVID-19

Scotland’s Minister for Trade, Investment and Innovation, Ivan McKee recently issued a statement to the Scottish Parliament regarding the COVID-19 crisis and Scotland’s life science sector’s support for and response to the COVID-19 pandemic.The accompanying report sets out the work of the sector including examples across test supply chain, vaccine development and repurposing of drugs and aims to provide a snapshot of… Read More

Race for the vaccine

We think this is a great overview and general summary of the challenges and process of making a new drug in relation to the current coronavirus crisis:On 16 March, a needle was put in the arm of a Seattle woman who may change the world.Jennifer Haller had a candidate vaccine against coronavirus injected into her bloodstream – the first human trial aimed… Read More

Is it really location, location, location in sterile manufacturing?

The pharmaceutical industry is a truly global sector. Within drug development, clinical trials are now conducted all over the world, so does it really matter where your sterile product manufacturer is based?Away from factors such as locality, one of the key drivers of this decision will be the regulation of injectable medicines. So what are the regulatory differences between say Europe and… Read More

Colin Mackay, CEO of Symbiosis

Steady growth in 2017 points to a successful year ahead for Symbiosis

Another year has passed here at Symbiosis HQ and I’m pleased to report that 2017 has been another strong year of sustained, profitable, growth for the company.Our underlying positive growth trend has continued, and aligns well with our strategic focus on developing the business in the North American market alongside our more established client base in Europe. Our efforts to proactively build… Read More

Colin Mackay, CEO of Symbiosis

A positive end to a positive year at Symbiosis

It may feel like only yesterday we were planning for 2016, but here we are at the end of another successful year. While the last 12 months have seemingly gone in a flash, it’s been another encouraging year at Symbiosis Pharmaceutical Services.With the support of our clients, staff, suppliers and partners, I’m pleased to say it’s been another steady year of growth… Read More

Qualified Person Release

The Good CMO Guide – What should small biotechs look for when outsourcing clinical trial manufacturing?

What kind of relationship are you looking for? It’s the first question that should be on the minds of biotech companies once the decision to outsource clinical trial manufacturing of parenterals to a CMO has been made. Is it a transactional relationship? One where a service is sourced and swiftly delivered without much in the way of long-term planning or on-going work… Read More

A review of BIO International Convention 2016

The dust has settled and it’s business as usual here in Stirling after BIO International Convention in San Francisco but we just wanted to take a moment to reflect on our main take-homes from the event…There is certainly a feeling of general buoyancy and positivity in the industry. It is clear that the investment community continues to see the biotech sector as… Read More

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.